Literature DB >> 16618429

Optimizing outcomes in hepatitis C: is treatment beyond 48 weeks ever justified?

Robert J Fontana.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16618429     DOI： 10.1053/j.gastro.2006.02.037

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  1 in total

Review 1.  [New data and recommendations of antiviral therapy of chronic hepatitis B and C].

Authors:  C Niederau
Journal:  Internist (Berl)       Date:  2008-10       Impact factor: 0.743
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.